Health Canada’s approval of ABRYSVO helps to address the urgent need to minimize the spread of RSV infections – a disease with flu-like symptoms that can result in respiratory distress1,2,3,… Read More
OTTAWA, ON – BioTalent Canada announced a new wage subsidy program that will accelerate the adoption of digital skills by small- and medium-sized businesses in Canada’s biosciences sector, better positioning… Read More
VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of disease, announced that Founder and CEO Tamer Mohamed will present… Read More
VANCOUVER, BC – Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco,… Read More
KIRKLAND, QC – Pfizer Canada ULC announced that Health Canada approved BEQVEZ (fidanacogene elaparvovec), an adeno-associated viral (AAV) vector-based gene therapy for the treatment of adults (aged 18 years or… Read More
